Salim Dhanji
iCo Therapeutics (Canada)(CA)
Publications by Year
Research Areas
Immune Cell Function and Interaction, T-cell and B-cell Immunology, Immune cells in cancer, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses
Most-Cited Works
- → Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8 + T-cell immunity(2011)311 cited
- → Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies(2009)225 cited
- → Impaired CD8 T cell memory and CD4 T cell primary responses in IL-7Rα mutant mice(2007)102 cited
- → Shp1 regulates T cell homeostasis by limiting IL-4 signals(2013)91 cited
- → IL-2-Activated CD8+CD44high Cells Express Both Adaptive and Innate Immune System Receptors and Demonstrate Specificity for Syngeneic Tumor Cells(2003)66 cited
- → IRAK‐4 kinase activity is required for IRAK‐4‐dependent innate and adaptive immune responses(2008)42 cited
- → Self-reactive memory-phenotype CD8 T cells exhibit both MHC-restricted and non-MHC-restricted cytotoxicity: a role for the T-cell receptor and natural killer cell receptors(2004)40 cited
- → SH2 Domain-Containing Protein-Tyrosine Phosphatases(2010)33 cited
- → The Low Affinity Fc Receptor for IgG Functions as an Effective Cytolytic Receptor for Self-Specific CD8 T Cells(2005)30 cited
- → RasGRP1 Transmits Prodifferentiation TCR Signaling That Is Crucial for CD4 T Cell Development(2006)22 cited